Research Papers:

Down regulation of human positive coactivator 4 suppress tumorigenesis and lung metastasis of osteosarcoma

Xu Hu, Chao Zhang, Ying Zhang, Christopher S. Hong, Wugui Chen, Weiwei Shen, Hongkai Wang, Jianrong He, Pei Chen, Yue Zhou, Chunmeng Shi _ and Tongwei Chu

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:53210-53225. https://doi.org/10.18632/oncotarget.18290

Metrics: PDF 1052 views  |   HTML 2029 views  |   ?  


Xu Hu1,*, Chao Zhang1,*, Ying Zhang1, Christopher S. Hong3, Wugui Chen1, Weiwei Shen1, Hongkai Wang1, Jianrong He1, Pei Chen1, Yue Zhou1, Chunmeng Shi2,** and Tongwei Chu1,**

1Department of Orthopedics, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China

2Institute of Combined Injury, State Key Laboratory of Trauma, Burns and Combined Injury, Chongqing Engineering Research Center for Nanomedicine, College of Preventive Medicine, Third Military Medical University, Chongqing, 400038, China

3The Ohio State University, College of Medicine, Columbus, OH, 43210, USA

*These authors contributed equally to this work

**These authors jointly directed this work

Correspondence to:

Chunmeng Shi, email: shicm@sina.com

Tongwei Chu, email: Chtw@sina.com

Keywords: PC4, SP1, MMP, pulmonary metastasis

Received: March 01, 2017    Accepted: May 10, 2017    Published: May 30, 2017


Osteosarcoma is a kind of primary malignant bone tumor with the highest incidence and an extraordinarily poor prognosis and early pulmonary metastasis formation as a frequent occurrence. Transcriptional positive coactivator 4 (PC4) has multiple functions in DNA replication, transcription, repair and chromatin organization, even in tumorigenesis. However, the precise function of PC4 in osteosarcoma is still unclear and controversial. In this paper we found PC4 was upregulated in patient-derived osteosarcoma tissues compared to normal. Moreover, higher expression of PC4 was correlated with poorer overall survival and advanced clinicopathological tumor staging. Down regulation of PC4 in the highly metastatic osteosarcoma cells reduced the malignant behaviors in vitro and in vivo. Analyzing the downstream genes affected obviously by shPC4 with RNA sequencing, we found knocking down PC4 will inhibit the propensity for lung metastasis through transcriptional suppression of MMPs pathways. Taken together, PC4 may be an attractive therapeutic strategy for osteosarcoma, especially in preventing lung metastasis formation.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 18290